Literature DB >> 7477666

Epidemiology of vascular dementia.

R Hébert1, C Brayne.   

Abstract

Vascular dementia (VaD) is the second commonest dementia after Alzheimer's disease (AD). Epidemiological studies of this condition suffer from many shortcomings related to definition of the disease, diagnostic criteria and assessment of subjects. The prevalence of VaD increases linearly with age and varies greatly from country to country, ranging from 1.2 to 4.2% of people over 65 years old, even after adjustment for age and sex. The incidence of VaD is more homogeneous than prevalence and is estimated at 6-12 cases per 1,000 persons over 70 years per year. The mean duration of the disease is around 5 years and survival is less than for the general population and for AD. The major risk factors for VaD appear to be hypertension, diabetes, heart disease and stroke. Although some of these risk factors are modifiable, there is no study on efficacy of prevention of VaD.

Entities:  

Mesh:

Year:  1995        PMID: 7477666     DOI: 10.1159/000109800

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  30 in total

Review 1.  A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.

Authors:  Jacob S Buckley; Shelley R Salpeter
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

Review 2.  Is apolipoprotein E4 an important risk factor for vascular dementia?

Authors:  Troy T Rohn
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  [Vascular dementia].

Authors:  N Peters; M Dichgans
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

Review 4.  The dementing disorders.

Authors:  H C Hendrie; F W Unverzagt; M G Austrom
Journal:  Psychiatr Q       Date:  1997

5.  [White matter lesions as a risk factor for stroke and dementia. A population-based study in 85-year-olds].

Authors:  M Liebetrau; G F Hamann; I Skoog
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

Review 6.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

7.  Pathophysiology of vascular dementia.

Authors:  Francesco Iemolo; Giovanni Duro; Claudia Rizzo; Laura Castiglia; Vladimir Hachinski; Calogero Caruso
Journal:  Immun Ageing       Date:  2009-11-06       Impact factor: 6.400

Review 8.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

9.  Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Authors:  Gary Small; Timo Erkinjuntti; Alexander Kurz; Sean Lilienfeld
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Vascular dementia: prevention and treatment.

Authors:  Catherine McVeigh; Peter Passmore
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.